hongjitang pharmaceutical strengthens its core competitiveness through innovation. it has more than 10 scientific research and innovation platforms including shandong provincial center for traditional chinese medicine treatment of respiratory diseases, strategic research center for traditional chinese medicine development, and shandong postdoctoral innovation practice base. research on a number of major topics at the same level. work closely with many academicians, masters of traditional chinese medicine, well-known scientific research institutes, hire many senior chinese medicine doctors as the honorary president of the research institute, on the one hand, around the existing 151 symbols for dosage form improvement, process improvement, clinical re-evaluation, etc. development research; on the other hand, focus on the field of traditional chinese medicine, focusing on the research of traditional chinese medicine new drugs, classic famous prescriptions, formula granules, replacement of rare and precious medicinal materials. jinbei oral liquid was approved in january 2020 as a preparation of shandong province medical institutions for the treatment of new crown patients in the province, and is expected to become the first innovative chinese medicine for the treatment of pulmonary fibrosis. hongjitang pharmaceutical is the only designated enterprise to produce qingfei detoxification mixture approved by shandong health commission, provincial administration of traditional chinese medicine and provincial drug administration. hongjitang pharmaceutical, as the first batch of enterprises in shandong province to study the formulation of traditional chinese medicine granules, the first phase of the 3,000-ton formula granule project has been put into production. according to the path from the provincial standard to the national standard, it will take the lead in the research of shandong province formulated granule standard. produce. the tousu artificial replacement project is expected to fill the gap in the new chinese patent medicine.
en.**.cn是山东宏济堂制药集团股份有限公司旗下网站，该网站属于综合其他行业。网站主要内容为：hong ji tang,hong ji tang等。网站前端技术使用swiper,bootstrap，网站后端技术使用amazon cloudfront。网站已经通过工信部备案，备案号为： 鲁icp备16043600号。已开启gzip压缩。
